158 related articles for article (PubMed ID: 25652294)
1. Atria are More Sensitive Than Ventricles to GS-458967-Induced Inhibition of Late Sodium Current.
Burashnikov A; Di Diego JM; Goodrow RJ; Belardinelli L; Antzelevitch C
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):501-8. PubMed ID: 25652294
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of physiological late Na
El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
[TBL] [Abstract][Full Text] [Related]
4. A computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late Na+ current.
Yang PC; Song Y; Giles WR; Horvath B; Chen-Izu Y; Belardinelli L; Rajamani S; Clancy CE
J Physiol; 2015 Mar; 593(6):1429-42. PubMed ID: 25545172
[TBL] [Abstract][Full Text] [Related]
5. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
Circulation; 2007 Sep; 116(13):1449-57. PubMed ID: 17785620
[TBL] [Abstract][Full Text] [Related]
6. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
[TBL] [Abstract][Full Text] [Related]
7. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
[TBL] [Abstract][Full Text] [Related]
8. Tolterodine reduces veratridine-augmented late I
Wang C; Wang LL; Zhang C; Cao ZZ; Luo AT; Zhang PH; Fan XR; Ma JH
Acta Pharmacol Sin; 2016 Nov; 37(11):1432-1441. PubMed ID: 27569391
[TBL] [Abstract][Full Text] [Related]
9. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization.
Qi D; Yang Z; Robinson VM; Li J; Gao C; Guo D; Kowey PR; Yan GX
Heart Rhythm; 2015 Jun; 12(6):1295-303. PubMed ID: 25684234
[TBL] [Abstract][Full Text] [Related]
11. Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.
Burashnikov A; Barajas-Martinez H; Hu D; Nof E; Blazek J; Antzelevitch C
J Cardiovasc Pharmacol; 2012 Jun; 59(6):539-46. PubMed ID: 22370957
[TBL] [Abstract][Full Text] [Related]
12. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
13. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.
Burashnikov A; Petroski A; Hu D; Barajas-Martinez H; Antzelevitch C
Heart Rhythm; 2012 Jan; 9(1):125-31. PubMed ID: 21884675
[TBL] [Abstract][Full Text] [Related]
14. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Song Y; Shryock JC; Wu L; Belardinelli L
J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis.
Hu D; Barajas-MartÃnez H; Burashnikov A; Panama BK; Cordeiro JM; Antzelevitch C
Int J Cardiol; 2016 Mar; 207():326-34. PubMed ID: 26820362
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes.
Guo D; Liu Q; Liu T; Elliott G; Gingras M; Kowey PR; Yan GX
J Cardiovasc Pharmacol; 2011 Jan; 57(1):79-85. PubMed ID: 20980921
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
Burashnikov A; Di Diego JM; Barajas-MartÃnez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
[TBL] [Abstract][Full Text] [Related]
18. [Effects of quinidine on pinacidil-induced transmural dispersion of repolarization in canine right ventricular wall].
Luo J; Yang XC; Wang LF; Zhou P; Li CL; Wang MS; Gao Y; Wang LZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):369-71. PubMed ID: 15932676
[TBL] [Abstract][Full Text] [Related]
19. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.
Sicouri S; Belardinelli L; Antzelevitch C
Heart Rhythm; 2013 Jul; 10(7):1036-43. PubMed ID: 23524321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
